Lionel Rostaing
Rostaing, Lionel, 19..-...., néphrologue
Rostaing, Lionel
VIAF ID: 193785518 (Personal)
Permalink: http://viaf.org/viaf/193785518
Preferred Forms
- 100 0 _ ‡a Lionel Rostaing
-
-
- 100 1 _ ‡a Rostaing, Lionel, ‡d 19..-...., ‡c néphrologue
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Bone histomorphometry and bone remodeling markers in renal transplantation : a study based on 21 kidney recipients. | |
Conversion to belatacept in stable kidney transplant recipients : a real-life scenario = Conversion au bélatacept chez les transplantés rénaux stables : expérience dans la vraie vie | |
Conversion to mTOR-inhibitors with adjunction of IV immunoglobulins in kidney-transplant recipients with BKV infection : a retrospective study. | |
Détection automatisée par deep learning de la viabilité lymphocytaire en microscopie sans lentille | |
Education program to reduce non compliance after renal transplantation. | |
Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux | |
Efficacité antivirale et tolérance d’un régime d’immunosuppression à base d’everolimus et tacrolimus faible dose en transplantation rénale | |
Efficacity and renal tolerance of Adefovir dipivoxil in transplanted patient with renal insufficiency for treatment of Lamivudine-resistant chronic hepatitis B. | |
Facteurs prédictifs de l'insuffisance rénale aigue͏̈ après transplantation hépatique orthotopique | |
Grossesse après transplantation rénale : retour d'expérience du CHU Grenoble Alpes | |
Hepatitis C in renal disease, hemodialysis, and transplantation | |
Improving access to kidney transplantation for hyperimmunized subjects : what place for tocilizumab in desensitization protocols ?. | |
Influence du DFG séparé pré don sur la fonction rénale du donneur et receveur après transplantation rénale avec donneur vivant. | |
Intérêt de la prophylaxie anti-CMV par valganciclovir chez les patients greffés rénaux séropositifs pour le CMV | |
Intérêt de l'histomorphométrie osseuse et des marqueurs du remodelage chez le transplanté rénal : étude sur une population de 21 patients hypercalcimiques | |
J’ai un DSA, c'est grave docteur ? Caractéristiques initiales et évolutives des anticorps spécifiques du greffon, formés de-novo, prédictives de la survie du greffon rénal chez les patients transplantés rénaux au CHU de Grenoble (étude DYNAMIK). | |
Modulation de la triade de costimulation CD28 / CD80-86 / CTLA-4 en transplantation rénale | |
Morbidity and mortality of renal transplant recipients aged 70 years and over. | |
New-onset diabetes and nephropathy after renal transplantation | |
A new surgical area opened in renal transplantation: a pure robot-assisted approach for both living donor nephrectomy and kidney transplantation using transvaginal route. | |
No evidence of occult hepatitis C virus | |
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial | |
Oxalate nephropathy associated with chronic pancreatitis | |
Patients' motives for consenting or refusing to participate in a clinical trial in organ transplantation. | |
Performance des formules d’estimation du débit de filtration glomérulaire chez les patients avec une obésité sévère et morbide | |
Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients | |
Peut-on améliorer l’accès à la liste d’attente de transplantation rénale en France ? | |
Poor long-term outcome in second kidney transplantation: a delayed event | |
Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation. | |
Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation | |
Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients | |
Predicting the risk for dialysis or death in IgA nephropathy. | |
Predictive factors of anemia in kidney transplantation. | |
Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation | |
Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor | |
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma | |
Range and consistency of outcomes reported in randomized trials conducted in kidney transplant recipients: a systematic review | |
Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions | |
Renal complications of liver diseases | |
Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid | |
Réponse vaccinale contre l’hépatite B dans une cohorte de patients transplantés rénaux : prévalence et persistance de la séroprotection | |
Réponses à long terme après traitement par interféron alpha chez des patients hémodyalisés chroniques porteurs d'une hépatite C | |
Review article: use of induction therapy in liver transplantation | |
Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function | |
Le risque rénal absolu (RRA) de dialyse ou décès chez les patients adultes avec néphropathie à IgA primaire (NIgA) : étude d'une cohorte prospective de néphropathie à IgA recrutée à Saint-Etienne (IGAN -STET-CO) | |
Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey | |
Rôle du complément dans le rejet humoral chez des patients transplantés rénaux : la positivité des anticorps anti-HLA fixant le C3d est corrélée à la MFI (Mean Fluorescence Intensity) en Luminex | |
The safety of calcineurin inhibitors for kidney-transplant patients | |
Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids | |
Severe cytomegalovirus ureteritis in a renal allograft recipient with negative CMV monitoring | |
Should kidney allografts from old donors be allocated only to old recipients? | |
Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients | |
Steroid-Based Therapy and Risk of Infectious Complications | |
Successful retransplantation of a kidney allograft affected by thrombotic microangiopathy into a second transplant recipient | |
Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation | |
Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients | |
Thésaurismose au silicone : à propos de trois observations cliniques | |
Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis. | |
Tocilizumab to treat microvascular inflammation after kidney transplantation : a propensity scorematching cohort analysis | |
Torque Teno Virus to monitor immunosuppression after conversion to Belatacept after kidney transplantation. | |
Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops | |
Traitement des transplantés rénaux infectés par le virus de l'hépatite C par ribavirine seule ; effets sur la fonction rénale et sur l'histologie hépatique | |
Transplantation: IdeS to desensitize organ allograft recipients. | |
Transplantation rénale chez patients âgés de 70 ans et plus : analyse rétrospective | |
Transplantation rénale HLA incompatible : évaluation des techniques d'aphérèses et à quel prix ?. | |
Transplantations hépatiques en France : bilan de l'emploi des immunosuppresseurs en 2004 | |
Treatment of hepatitis E virus infection | |
Treatment of refractory myasthenia gravis by double-filtration plasmapheresis and rituximab: A case series of nine patients and literature review | |
Treatment of symptomatic transplant glomerulopathy with rituximab. | |
Unusual presentation of cytomegalovirus infection in patients after organ transplant |